SCHEMBL4188845

SCHEMBL4188845

N#C/C(=C/c1ccccc1O)S(=O)(=O)Cc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SENP1 Q9P0U3 1/20 0.40
PKM P14618 2/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
BCL2A1 Q16548 1/20 0.39
PPME1 Q9Y570 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
NSD2 O96028 1/20 0.38
IDE P14735 1/20 0.38
BRAF P15056 1/20 0.38
HSP90AA1 P07900 1/20 0.38
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
OXTR P30559 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188848 1.00 MEN1 (0.43) MEN1KMT2ASENP1PKMMAPT
SCHEMBL4188837 1.00 MEN1 (0.43) MEN1KMT2ASENP1PKMMAPT
SCHEMBL4179284 0.91 ALDH1A1 (0.43) MEN1KMT2ASENP1PKMMAPT
SCHEMBL4179275 0.91 ALDH1A1 (0.43) MEN1KMT2ASENP1PKMMAPT
SCHEMBL4179281 0.91 ALDH1A1 (0.43) MEN1KMT2ASENP1PKMMAPT
SCHEMBL4173145 0.85 HSP90AA1 (0.44) MEN1KMT2AMAPTMAPK1NSD2
SCHEMBL4173138 0.85 HSP90AA1 (0.44) MEN1KMT2AMAPTMAPK1NSD2
SCHEMBL4173142 0.85 HSP90AA1 (0.44) MEN1KMT2AMAPTMAPK1NSD2
SCHEMBL4184690 0.84 ERCC1 (0.46) MEN1KMT2ASENP1PKMMAPT
SCHEMBL4184693 0.84 ERCC1 (0.46) MEN1KMT2ASENP1PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 MEN1 2503/4885KMT2A 469/4885SENP1 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.